SCHEMBL6748121

SCHEMBL6748121

CCOC(=O)S(=O)(=O)c1ccc([N+](=O)[O-])cc1

nearest known ligand 0.56

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PKM P14618 2/20 0.51
HPGD P15428 2/20 0.51
RAB9A P51151 1/20 0.51
ALDH1A1 P00352 3/20 0.50
GAA P10253 1/20 0.50
MAPT P10636 3/20 0.49
LMNA P02545 2/20 0.49
SMN1; SMN2 Q16637 2/20 0.49
ACHE P22303 1/20 0.48
HSD17B10 Q99714 1/20 0.48
NOD2 Q9HC29 1/20 0.48
NOD1 Q9Y239 1/20 0.48
CYP1A2 P05177 1/20 0.48
CYP3A4 P08684 1/20 0.48
CYP2D6 P10635 1/20 0.48
THRB P10828 1/20 0.48
CYP2C9 P11712 1/20 0.48
CYP2C19 P33261 1/20 0.48
KMT2A Q03164 2/20 0.48
POLB P06746 1/20 0.48

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL27682339 0.84 FKBP1A (0.55) PKMHPGDALDH1A1GAAMAPT
SCHEMBL9652368 0.83 KMT2A (0.54) RAB9AALDH1A1GAAMAPTLMNA
SCHEMBL22038769 0.81 POLB (0.59) HPGDALDH1A1GAACYP3A4CYP2C19
SCHEMBL3934292 0.81 HPGD (0.49) PKMHPGDRAB9AALDH1A1GAA
SCHEMBL8549453 0.80 ALDH1A1 (0.46) RAB9AALDH1A1GAAMAPTLMNA
SCHEMBL3940421 0.79 MAPT (0.48) PKMHPGDRAB9AALDH1A1GAA
SCHEMBL874868 0.78 KMT2A (0.68) PKMHPGDRAB9AALDH1A1GAA
SCHEMBL1255111 0.78 KCNJ1 (0.51) PKMHPGDRAB9AALDH1A1GAA
SCHEMBL6024157 0.78 ALDH1A1 (0.54) HPGDRAB9AALDH1A1GAALMNA
SCHEMBL30259414 0.77 ALDH1A1 (0.48) PKMHPGDALDH1A1MAPTLMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040142946-A1 Modified nucleosides and nucleotides and use thereof CHATTOPADHYAYA JYOTI (SE) 2004-07-22 US claimed
EP-1332150-A1 MODIFIED NUCLEOSIDES AND NUCLEOTIDES AND USE THEREOF Chattopadhyaya, Jyoti (SE) 2003-08-06 EP claimed
WO-2002038578-A1 MODIFIED NUCLEOSIDES AND NUCLEOTIDES AND USE THEREOF CHATTOPADHYAYA JYOTI (SE) 2002-05-16 WO claimed
US-5721350-A Deuterated nucleosides CHATTOPADHYAYA JYOTI (SE) 1998-02-24 US claimed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040142946-A1 Modified nucleosides and nucleotides and use thereof RNASEH1, RNASEL, NSUN2 PKM 4441/4885HPGD 4134/4885RAB9A 2659/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.